Story perspectives
New Lymphoma Therapy 43x More Effective in Trials
6/4/2025
40 7
1 of 1
Story summary
- A groundbreaking lymphoma therapy has emerged from the Paul Scherrer Institute and Inselspital–Bern University Hospital, utilizing the radioactive isotope terbium-161. This innovative treatment specifically targets CD30 receptors in cancer cells, boasting an impressive 43 times more effectiveness than the current standard, lutetium-177. Early mouse trials show great promise, setting the stage for future human clinical trials.
